ImaginAb (Next-Generation Therapeutic Assets and Innovative Biologics Technology Platform) Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
Asset Purch.
- Financing Rounds
-
1
ImaginAb (Next-Generation Therapeutic Assets and Innovative Biologics Technology Platform) General Information
Description
Therapeutic assets and innovative biologics technology platform. The assets include a pipeline of next-generation therapeutic candidates, a proprietary novel biologics technology platform and a protein engineering and discovery research facility.
Contact Information
Corporate Office
- Inglewood, CA
- United States
Corporate Office
- Inglewood, CA
- United States
ImaginAb (Next-Generation Therapeutic Assets and Innovative Biologics Technology Platform) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
ImaginAb (Next-Generation Therapeutic Assets and Innovative Biologics Technology Platform) Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
ImaginAb (Next-Generation Therapeutic Assets and Innovative Biologics Technology Platform) FAQs
-
Where is ImaginAb (Next-Generation Therapeutic Assets and Innovative Biologics Technology Platform) headquartered?
ImaginAb (Next-Generation Therapeutic Assets and Innovative Biologics Technology Platform) is headquartered in Inglewood, CA.
-
What industry is ImaginAb (Next-Generation Therapeutic Assets and Innovative Biologics Technology Platform) in?
ImaginAb (Next-Generation Therapeutic Assets and Innovative Biologics Technology Platform)’s primary industry is Buildings and Property.
-
Is ImaginAb (Next-Generation Therapeutic Assets and Innovative Biologics Technology Platform) a private or public company?
ImaginAb (Next-Generation Therapeutic Assets and Innovative Biologics Technology Platform) is a Private company.
-
What is the current valuation of ImaginAb (Next-Generation Therapeutic Assets and Innovative Biologics Technology Platform)?
The current valuation of ImaginAb (Next-Generation Therapeutic Assets and Innovative Biologics Technology Platform) is .
-
What is ImaginAb (Next-Generation Therapeutic Assets and Innovative Biologics Technology Platform)’s current revenue?
The current revenue for ImaginAb (Next-Generation Therapeutic Assets and Innovative Biologics Technology Platform) is .
-
Who are ImaginAb (Next-Generation Therapeutic Assets and Innovative Biologics Technology Platform)’s investors?
ImaginAb has invested in ImaginAb (Next-Generation Therapeutic Assets and Innovative Biologics Technology Platform).
-
When was ImaginAb (Next-Generation Therapeutic Assets and Innovative Biologics Technology Platform) acquired?
ImaginAb (Next-Generation Therapeutic Assets and Innovative Biologics Technology Platform) was acquired on 30-Jan-2025.
-
Who acquired ImaginAb (Next-Generation Therapeutic Assets and Innovative Biologics Technology Platform)?
ImaginAb (Next-Generation Therapeutic Assets and Innovative Biologics Technology Platform) was acquired by Telix Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process